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Abstract
Objective: To describe a patient with erhythema and edema after Radix Astragali was added to a kampo formula.
Case summary: A 21-year-old male, who was diagnosed as having atopic dermatitis in 1989, demonstrated systemic dry eruptions and 
consulted our department for treatment with traditional herbal medicine (THM) in 2004. The oral administration of herbal medicine 
resulted in decreased symptoms as well as a reduction in the serum IgE level. In August 2007, he complained of sweating on the neck 
and we added Radix Astragali to the previous formula. About 18 hours after he ingested the new formula including Radix Astragali, 
erhythema appeared with swelling of the bilateral hands and feet. Administration of the formula was discontinued and about 48 hours 
later, his symptoms had almost disappeared. Astragaloside, which is the main ingredient of Radix Astragali, was negative on lympho-
cyte transforming test (LTT) and we could not determine the ingredient that induced erhythema.
Conclusion: We consider that the Radix Astragali induced acute erhythema with swelling based on the clinical course. Acute edematous 
erythema due to THM is very rare and we discuss allergic reactions to traditional herbs and review the litrature.
Keywords: Radix astragali, erhythema, allergic reaction, lymphocyte transforming test, traditional herbal medicine (Kampo)Kogure et al
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Introduction
Radix astragali, OgiR is prepared from the root of 
Astragalus  membranaceus  Bunge  or A.  mongholi-
cus  Bunge,  and  is  one  of  the  representative  herbs 
used  in  the  field  of  traditional  herbal  medicine 
(THM: called Kampo in Japan). The main compo-
nents consist of flavonoids such as formononetin, 3’- 
hydroxyformononetin, l-canavanin and saponins such 
as  astragaloside,  sayasaponin. This  herb  is  usually 
used in the form of decoctions having a tonic-effect. 
It has been reported that this drug has pharmacologi-
cal actions such as immunomodulatory effects, anti-
inflammatory effects and anti-allergic effects.1,2
This paper describes a rare case of a patient with 
atopic  dermatitis  (AD)  demonstrating  edematous 
  erythema  thought  to  be  caused  by  adding  Radix 
  astragali to a kampo formula.
case Report
The patient consulted our hospital in April 2004 at 
21 years of age, with systemic dry eruptions associ-
ated with AD.
In  1989,  he  developed  systemic  eruption  with 
itching and was diagnosed as having AD at a local 
hospital.  He  was  treated  with  ointment  contain-
ing steroids and his condition periodically became 
somewhat better or worse. However, his symptoms 
gradually worsened recently and the use of ointment 
containing  steroids  was  discontinued.  Thereafter, 
he consulted our hospital with a request for herbal 
medicine in 2004. At the first medical examination 
in April 2004, he had severe dry eruptions on the 
neck, chest, bilateral upper and lower extremities, 
especially,  eczema  with  lichen  on  the  neck.  His 
  laboratory data were as follow: White blood cell: 
7400/mm3,  eosinophil:  14.9%,  immunoglobulin 
(Ig)-E:  15012.6  mg/dl,  C-reactive  protein  (CRP): 
0.1 mg/dl, lactate dehydrogenase (LDH): 226IU/l. 
Hepatic,  renal  and  thyroid  function  was  normal. 
Kagen-ichiin-sen (KIS; decoction: Uchida Co. Ltd 
Tokyo Japan; Table 1 ) was prescribed per mouth 
daily, based on the traditional diagnostic system.3 
Briefly, the indications for KIS are eczema and pru-
ritis with dry skin and dotty or diffuse pigmenta-
tion. The oral intake of KIS resulted in a decrease 
in symptoms as well as a reduction of the serum IgE 
level (3863.7 mg/dl) on Feb. 2007.
In August 2007, he complained of sweating on the 
neck and we added Radix Astragali to KIS, since the 
indication for Radix Astragali is eruptive eczema with 
sweat.3 However, about 18 hours after he ingested the 
full day’s dose (twice a day) including Radix Astragali, 
erhythema with swelling of the bilateral hands and 
feet appeared (Fig. 1A). There was no swelling of 
the superficial lymph nodes. Although the eosinophil 
count and serum LDH level did not change, the serum 
Table 1. Herbs composed of Kagenichiin-sen.
component Volume (gram)
radix rehmanniae 20
radix paeoniae 6
ophinopgonis tuber 6
Lycii radicis cortex 3
Anemarrhenae rhizoma 3
radix glycyrrhizae 3
Asini corli collas 1
Chinemys reevesii 0.5
Radix astragali* 5
note: The herbs were mixed with 600 mL of water and boiled down 
to 300 mL, and the aqueous extract was filtered through a sieve. The 
extract, called a decoction, was administered 3 times a day before meals. 
*Astragali radix was added on Aug 2007.
Figure  1.  A)  eighteen  hours  after  administration  of  radix Astragali. 
edematous erythema with a sensation of heat at the hands and feet. 
Upper panel: the palm, Middle panel: the back of hands, Lower panel: feet. 
B)  Forty-eight  hours  after  discontinuation  of  radix  Astragali  intake. 
edematous erythema had almost disappeared.edematous erythema 
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CRP level increased slightly (0.3 mg/dl). Anti-nuclear 
antibody was negative, and there were no apparent 
monoclonal  gammopathies.  Administration  of  the 
altered formula was discontinued and 2 days later, 
his symptoms had almost disappeared (Fig. 1B) and 
the serum CRP level was ,0.1 mg/dl. Thereafter, he 
continued intake of the original KIS formula and his 
condition stablized.
Analysis by LTT using herbal ingredient
The patient refused oral provocation with a low con-
centration  of  Radix  Astragali.  Therefore,  lympho-
cyte transformation test (LTT) was performed with 
his consent. LTT for THM is unreliable because of 
the likelihood of a false positive results.4 Thus, LTT 
for the main ingredient of Radix astragali was uti-
lized, and as a result astragaloside was negative on 
LTT (Table 2). This assessment was approved under 
the  comprehensive  agreement  provided  by  Gunma 
  University Hospital.
Discussion
THM, which is covered by national health insurance 
in Japan, is generally used in the field of primary 
health care, and is also administered as an alternative 
remedy for chronic diseases such as AD. Although it 
is considered that THM is generally a safe drug, some 
adverse effects are known. Drug eruption is an occa-
sional adverse effect in THM and several cases have 
been  reported.5–11  Recently  reported  cases  of  drug 
eruptions due to THM are summarized in Table 3. 
Discontinuation of each drug resulted in the improve-
ment of drug eruptions in all cases. Two cases of 
drug eruption induced by Radix Astragali have been 
reported, one patient (No. 7) showed lichenoid planus 
3 weeks after the start of Radix Astragali intake. In 
contrast,  another  patient  (No.  2)  showed  edema-
tous erythema with fever and oliguria that appeared 
24  hours  after  taking  medicines  containing  Radix 
Astragali.  Although  physicians  consider  that  drug 
eruption due to THM is generally mild, it should be 
understood that a few patient may show acute edema-
tous erythema such as erythroderma. Generally, ery-
thema with a heat sensation in erythroderma spreads 
over the whole body within 12–48 hours. The present 
case also showed edematous erythema 18 hours after 
the drug-intake, but erythema involved the hands and 
feet. It is unclear whether the present patient would 
have developed an acute erythroderma if the admin-
istration of Radix astragali had continued.
Incidentally, in this case it was nesessary to rule 
out hereditary/acquired angioedema in the differen-
tial diagnoses. Unfortunately, we failed to measure 
the  complements  (eg,  Serum  C1q/C3/C4)  and  C1 
esterase inhibitor. Therefore, we are not able to diag-
nose the allergic edematous erythema more precisely. 
However, we regarded the clinical manifestation of 
the present patient as allergic edematous erythema 
because of the improvement following discontinua-
tion of drug, absence of monoclonal gammanopathy 
and  absence  of  any  classification  for  autoimmune 
diseases.
Although Radix astragali have several   bioactivities 
such  as  immunomodulatory  and  the  vasodilative 
effects,1,2 there was a limited quantity of the compo-
nents of Radix astragali in the decoction. Therefore, 
edematous erythema is probably induced by an aller-
gic response to Radix astragali. Generally, it is dif-
ficult to confirm that a traditional herb must be the 
causative drug in an allergic reaction. LTT for THM 
is unreliable because of the likelihood of false posi-
tive results.4 Therefore, we performed LTT using only 
the main component of Radix astragali. However, the 
causative ingredient could not be confirmed. There 
are two possibilities for these results: one is the like-
lihood of a causative components other than astra-
galoside and another is that plural components (crude 
drug) may be associated with the allergic reaction. 
Table 2. The results of lymphocyte transformation test for herbal ingredients.
no treatment pHA#  Astragaloside saikosaponin**
Max response (cpm) 144 1999303 172 199
Max S.I.* 1 1384.0 1.2 1.4
notes: *Stimulation Index: astragaloside or saikosaponin/no treatment; **Saikosaponin was utilized as negative control among herbal ingredient, #pHA, 
phytohemagglutinin.Kogure et al
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In fact, it is considered that interstitial   pneumonia 
induced by Shosaikoto is probably an allergic reac-
tion for the crude drug: shosaikoto.12 To certify the 
causative drug in the field of dermatology, patch test 
using crude drug has became prevalant. Evaluating 
previous reports, the patch test was carried out in 5 
cases (No. 2, 3, 5, 6, 7 in Table 2). Three cases (No. 2, 
3, 5) showed positive results and the causative drug 
was  determined.  In  contrast,  2  patients  (No.  6,  7) 
had negative results, but interestingly, these patients 
agreed to an oral ingestion challenge test and showed 
positive results. Therefore, we consider that assess-
ment of the clinical course must be important when 
prescribing crude drugs such as traditional herbs.
Another  important  question  is  whether  a  high 
serum level of IgE may have been associated with 
the  occurrence  of  allergic  edematous  erythema  in 
this  patient. There  is  no  report  demonstrating  that 
drug allergy occurs more often in patients with AD 
in comparison with healthy subjects. Based on sev-
eral investigations,13,14 it is generally considered that 
a high serum level of IgE in AD patients is a result, 
not a cause. However, it is known that a high serum 
IgE condition increases IgE-mediated type I hyper-
sensitivity reaction through Fc ε receptorI (Fc ε RI) 
on mast cells.15 Possibly, edematous erythema hav-
ing occurred in this patient was caused by an IgE-
  mediated allergic mechanism. Therefore, it is possible 
that edematous erythema might have been induced by 
Radix astragali due to the high serum levels of IgE in 
this patient. However, we could not identify a caus-
ative  component  using  LTT.  Since  LTT  examines 
lymphocyte  (non-IgE)-mediated  allergic  reactions, 
LTT might fail to show the positive result.
Herein, we presented a case of an atopic dermati-
tis with acute edematous erythema caused by Radix 
astragali. While the causative component could not 
be determined by LTT, it is estimated that the edem-
atous  erythema  must  have  been  caused  by  Radix 
astragali based on the clinical course of this patient. 
In eruptions caused by crude drugs, the causative 
agent should be determined from a comprehensive 
perspective.5
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